Brief: Xbrane Biopharma Q2 Revenues Amounted To SEK 4.5 mln

Xbrane Biopharma AB

24/08/2018 07:13

Aug 24 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * Q2 REVENUES AMOUNTED TO SEK 4,532 THOUSAND (4,444)
    * Q2 EBITDA AMOUNTED TO SEK -30,453 THOUSAND (-6,897)

Source text for Eikon:  ID:nGNE3csClQ 
Further company coverage:  XBRANE.ST 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))